{
    "organizations": [],
    "uuid": "ab998f47ac5c5572634051a0a8efc5bd5572f690",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-foamix-reports-fiscal-year-2017-fi/brief-foamix-reports-fiscal-year-2017-financial-results-and-provides-corporate-update-idUSASB0C7ZT",
    "ord_in_thread": 0,
    "title": "BRIEF-Foamix Reports Fiscal Year 2017 Financial Results And Provides Corporate Update",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Foamix Pharmaceuticals Ltd:\n* FOAMIX REPORTS FISCAL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* FOAMIX PHARMACEUTICALS LTD - AT DECEMBER 31, 2017, HAD $76.4 MILLION IN CASH AND INVESTMENTS COMPARED TO $131 MILLION AT END OF DECEMBER 2016 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-02-28T21:11:00.000+02:00",
    "crawled": "2018-03-01T21:00:54.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "foamix",
        "pharmaceutical",
        "ltd",
        "foamix",
        "report",
        "fiscal",
        "year",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "foamix",
        "pharmaceutical",
        "ltd",
        "december",
        "million",
        "cash",
        "investment",
        "compared",
        "million",
        "end",
        "december",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}